Virbac has announced the European launch of Vikaly, the world's first medicated feed for cats combining renal kibble with a veterinary drug subject to marketing authorization.
The product requires veterinary prescription following clinical examination and is produced in a factory approved for medicated feed manufacture. Distribution follows European Regulation 2019/4 requirements.
"The story began more than 15 years ago, with the idea of combining an essential medication with food, to improve the quality of life of cats with chronic diseases and make life easier for their owners," said Bertrand Havrileck, group R&D director. "Today, we are proud to see this vision become a reality with the launch of the world's first medicated pet food."
The product inaugurates a new regulatory category in Europe. Virbac designed, developed and manufactured Vikaly entirely in France at its Carros and Vauvert facilities.
"With this solution, Virbac aims to sustainably evolve care protocols in veterinary medicine, while contributing to the well-being of companion animals," said Nathalie Pollet, global marketing director and member of the Group Management Committee.
The manufacturing process uses spraying technology to coat each kibble homogeneously with active ingredient. The medicated premix is produced in Carros, with incorporation into feed at the Vauvert site.
Virbac, founded in 1968, employs more than 6,400 people worldwide and markets products in over 100 countries. The company said it ranks sixth globally in animal health, with turnover of 1.397 billion euros in 2024.
